Global Inhaled Nitric Oxide Market Growth 2023-2029

Global Inhaled Nitric Oxide Market Growth 2023-2029

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

LPI (LP Information)' newest research report, the “Inhaled Nitric Oxide Industry Forecast” looks at past sales and reviews total world Inhaled Nitric Oxide sales in 2022, providing a comprehensive analysis by region and market sector of projected Inhaled Nitric Oxide sales for 2023 through 2029. With Inhaled Nitric Oxide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhaled Nitric Oxide industry.

This Insight Report provides a comprehensive analysis of the global Inhaled Nitric Oxide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhaled Nitric Oxide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Inhaled Nitric Oxide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhaled Nitric Oxide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhaled Nitric Oxide.

The global Inhaled Nitric Oxide market size is projected to grow from US$ 1060.4 million in 2022 to US$ 1890.5 million in 2029; it is expected to grow at a CAGR of 1890.5 from 2023 to 2029.

Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhaled Nitric Oxide market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

800 ppm

100 ppm

Others

Segmentation by application

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Inhaled Nitric Oxide market?

What factors are driving Inhaled Nitric Oxide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Inhaled Nitric Oxide market opportunities vary by end market size?

How does Inhaled Nitric Oxide break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.